MURINE MACROPHAGE INTERLEUKIN-1 RELEASE BY CAPSULAR-LIKE SEROTYPE-SPECIFIC POLYSACCHARIDE ANTIGENS OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS

被引:56
作者
TAKAHASHI, T
NISHIHARA, T
ISHIHARA, Y
AMANO, K
SHIBUYA, N
MORO, I
KOGA, T
机构
[1] NATL INST HLTH,DEPT DENT RES,SHINAGAWA KU,TOKYO 141,JAPAN
[2] NIHON UNIV,SCH DENT,DEPT PATHOL,CHIYODA KU,TOKYO 101,JAPAN
[3] NATL INST AGROBIOL RESOURCES,DEPT CELL BIOL,TSUKUBA 305,JAPAN
关键词
D O I
10.1128/IAI.59.1.18-23.1991
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serotype-specific polysaccharide antigens (SPAs) were extracted from whole cells of Actinobacillus actinomycetemcomitans ATCC 29523 (serotype a), Y4 (serotype b), and NCTC 9710 (serotype c) by autoclaving and purified by chromatography on DEAE-Sephadex A-25 and Sephacryl S-300 columns. Y4 SPA induced interleukin-1 (IL-1) release by P388D1 murine macrophages. Polymyxin B had virtually no effect on the release of IL-1. Rabbit anti-murine IL-1 serum strongly suppressed the proliferation of C3H/HeJ mouse thymocytes induced with the culture supernatants of Y4 SPA-stimulated P388D1 cells and a submitogenic dose of concanavalin A. Gel filtration of the culture supernatants of Y4 SPA-stimulated macrophages on Sephacryl S-200 showed that an IL-1 peak at a point corresponding to approximately 16.5 kDa was eluted. The ability of SPAs from strains ATCC 29523 and NCTC 9710 to induce the release of IL-1 was lower than that of Y4 SPA. The IL-1-releasing ability of serotype a and c antigens was enhanced by deacetylation of both polysaccharides, suggesting that acetyl groups of these antigens might hinder the interaction between the antigens and macrophages.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 29 条
[1]   IMMUNOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF A SEROTYPE-SPECIFIC POLYSACCHARIDE ANTIGEN FROM ACTINOBACILLUS-ACTINOMYCETEMCOMITANS-Y4 (SEROTYPE-B) [J].
AMANO, K ;
NISHIHARA, T ;
SHIBUYA, N ;
NOGUCHI, T ;
KOGA, T .
INFECTION AND IMMUNITY, 1989, 57 (10) :2942-2946
[2]   THE INVITRO EFFECT OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS STRAIN Y4-LIPOPOLYSACCHARIDE ON MURINE PERITONEAL-MACROPHAGES [J].
BARKER, KA ;
HOLT, SC .
CANADIAN JOURNAL OF MICROBIOLOGY, 1983, 29 (11) :1552-1563
[3]  
BILLIAU A, 1988, MONOKINES OTHER NONL, P3
[4]   DIFFERENTIATION BETWEEN ACTINOBACILLUS-ACTINOMYCETEMCOMITANS AND HEMOPHILUS-APHROPHILUS BASED ON CARBOHYDRATES IN LIPOPOLYSACCHARIDE [J].
BRONDZ, I ;
OLSEN, I .
JOURNAL OF CHROMATOGRAPHY, 1984, 310 (02) :261-272
[5]   IMMUNODOMINANT ANTIGEN OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS Y4 IN HIGH-RESPONDER PATIENTS [J].
CALIFANO, JV ;
SCHENKEIN, HA ;
TEW, JG .
INFECTION AND IMMUNITY, 1989, 57 (05) :1582-1589
[6]   LIPOPOLYSACCHARIDE-STIMULATED PGE2 RELEASE FROM HUMAN-MONOCYTES - COMPARISON OF LIPOPOLYSACCHARIDES PREPARED FROM SUSPECTED PERIODONTAL PATHOGENS [J].
GARRISON, SW ;
HOLT, SC ;
NICHOLS, FC .
JOURNAL OF PERIODONTOLOGY, 1988, 59 (10) :684-687
[7]  
HARVEY W, 1987, IMMUNOLOGY, V60, P415
[8]  
KAPLAN AH, 1989, REV INFECT DIS, V11, P46
[9]   SMOOTH LIPOPOLYSACCHARIDE IS THE MAJOR PROTECTIVE ANTIGEN FOR MICE IN THE SURFACE EXTRACT FROM IATS SEROTYPE 6 CONTRIBUTING TO THE POLYVALENT PSEUDOMONAS-AERUGINOSA VACCINE PEV [J].
MACINTYRE, S ;
LUCKEN, R ;
OWEN, P .
INFECTION AND IMMUNITY, 1986, 52 (01) :76-84
[10]  
MIZEL SB, 1978, J IMMUNOL, V120, P1504